AstraZeneca: COVID vaccine 79% effective in U.S. trial - Morning Briefing - Marketplace Minute - March 22, 2021
Drugmaker says vaccine fully prevents severe COVID illness; IMF to upgrade world economic forecast; Canadian Pacific Railway strikes deal to purchase Kansas City Southern for $25 billion